Atopic dermatitis

Last updated: November 05, 2025

Atopic dermatitis

PGreen

PGreen

Cell-cell junctions
Marfan syndrome
Cellular structure and function
Development of the renal system
Mitosis and meiosis
Colorectal polyps and cancer: Pathology review
Endometrial hyperplasia and cancer: Clinical
Lung cancer
Metaplasia and dysplasia
Oral cancer
Testicular cancer
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Acute respiratory distress syndrome
Arterial disease
Asthma
Atrial septal defect
Bronchiectasis
Chronic bronchitis
Chronic venous insufficiency
Angina pectoris
Aortic valve disease
Coarctation of the aorta
Heart failure
Pneumonia
Tetralogy of Fallot
Shock
Mitral valve disease
Pericarditis and pericardial effusion
Pleural effusion
Dementia: Pathology review
Dementia: Pathology review
Dementia: Pathology review
Dementia: Pathology review
Dementia: Pathology review
Anxiety disorders: Clinical
Arteriovenous malformation
Bipolar and related disorders
Cauda equina syndrome
Seizures and epilepsy
Generalized anxiety disorder
Headaches: Pathology review
Huntington disease
Ischemic stroke
Major depressive disorder
Meningitis
Migraine
Multiple sclerosis
Panic disorder
Parkinson disease
Stroke: Clinical
Alzheimer disease
Diabetes mellitus: Pathology review
Adrenocorticotropic hormone
Chlamydia trachomatis
Cortisol
Cushing syndrome
Endometriosis
Glucagon
Glucocorticoids
Herpes simplex virus
HIV (AIDS)
Hyperthyroidism: Pathology review
Hypothyroidism: Pathology review
Hypothyroidism
Insulin
Pelvic inflammatory disease
Testosterone
Polycystic ovary syndrome
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Thyroid hormones
Anemia of chronic disease
Chronic leukemia
Coagulation disorders: Pathology review
Disseminated intravascular coagulation
Factor V Leiden
Hemophilia
Non-Hodgkin lymphoma
Hypocalcemia
Hypokalemia
Inflammation
Innate immune system
Introduction to the immune system
Iron deficiency anemia
Leukemias: Pathology review
Platelet disorders: Pathology review
Sickle cell disease (NORD)
Type IV hypersensitivity
Acute cholecystitis
Acute pancreatitis
Acute pyelonephritis
Alcohol-associated liver disease
Appendicitis
Autoimmune hepatitis
Biliary colic
Bowel obstruction
Chronic cholecystitis
Chronic pyelonephritis
Chronic pancreatitis
Cirrhosis
Congenital disorders: Clinical
Crohn disease
Gastroesophageal reflux disease (GERD)
Irritable bowel syndrome
Lower urinary tract infection
Nephrotic syndromes: Pathology review
Peptic ulcer
Renal failure: Pathology review
Ulcerative colitis
Urinary tract infections: Pathology review
Viral hepatitis
Acne vulgaris
Atopic dermatitis
Back pain: Pathology review
Bone disorders: Pathology review
Burns
Osteoarthritis
Osteoporosis
Paget disease of bone
Psoriasis
Rheumatoid arthritis
Skin cancer
Varicella zoster virus
Down syndrome (Trisomy 21)
Inheritance patterns
DNA damage and repair
DNA replication
Selective permeability of the cell membrane
Cell cycle
Free radicals and cellular injury
Autosomal trisomies: Pathology review
Breast cancer: Pathology review
Hypertension: Pathology review
Deep vein thrombosis
Emphysema
Endocarditis
Gas exchange in the lungs, blood and tissues
Peripheral artery disease
Pulmonary edema
Restrictive lung diseases
Stroke volume, ejection fraction, and cardiac output
Ventilation-perfusion ratios and V/Q mismatch
Cranial nerves
Migraine
Myasthenia gravis
Abnormal uterine bleeding: Clinical
Neisseria gonorrhoeae
Primary adrenal insufficiency
Benign prostatic hyperplasia
Hodgkin lymphoma
Introduction to the immune system
Celiac disease
Introduction to pharmacology
Drug administration and dosing regimens
Enzyme function
Pharmacokinetics: Drug metabolism
Pharmacokinetics: Drug elimination and clearance
Pharmacokinetics: Drug absorption and distribution
Pharmacodynamics: Drug-receptor interactions
Pharmacodynamics: Desensitization and tolerance
Pharmacodynamics: Agonist, partial agonist and antagonist
Opioid antagonists
Opioid agonists, mixed agonist-antagonists and partial agonists
Opioid use disorder
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs
Anticoagulants: Direct factor inhibitors
Anticoagulants: Heparin
Anticoagulants: Warfarin
Antiplatelet medications
Thrombolytics
Hematopoietic medications
Role of Vitamin K in coagulation
Vitamin B12 deficiency
Loop diuretics
Miscellaneous lipid-lowering medications
Potassium sparing diuretics
Adrenergic antagonists: Alpha blockers
Calcium channel blockers
Lipid-lowering medications: Fibrates
Lipid-lowering medications: Statins
Adrenergic antagonists: Beta blockers
Class II antiarrhythmics: Beta blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Class III antiarrhythmics: Potassium channel blockers
Class I antiarrhythmics: Sodium channel blockers
Thiazide and thiazide-like diuretics
ACE inhibitors, ARBs and direct renin inhibitors
Positive inotropic medications
Vaccinations
Anthelmintic medications
Anti-mite and louse medications
Antimalarials
Hepatitis medications
Integrase and entry inhibitors
Antimetabolites: Sulfonamides and trimethoprim
Azoles
Cell wall synthesis inhibitors: Cephalosporins
Cell wall synthesis inhibitors: Penicillins
DNA synthesis inhibitors: Metronidazole
DNA synthesis inhibitors: Fluoroquinolones
Echinocandins
Herpesvirus medications
Mechanisms of antibiotic resistance
Miscellaneous cell wall synthesis inhibitors
Miscellaneous protein synthesis inhibitors
Neuraminidase inhibitors
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Nucleoside reverse transcriptase inhibitors (NRTIs)
Protease inhibitors
Protein synthesis inhibitors: Aminoglycosides
Protein synthesis inhibitors: Tetracyclines
Antihistamines for allergies
Miscellaneous antifungal medications
Androgens and antiandrogens
Aromatase inhibitors
Estrogens and antiestrogens
PDE5 inhibitors
Progestins and antiprogestins
Uterine stimulants and relaxants
Acid reducing medications
Antidiarrheals
Laxatives and cathartics
Non-corticosteroid immunosuppressants and immunotherapies
Hyperthyroidism medications
Hypoglycemics: Insulin secretagogues
Hypothyroidism medications
Insulins
Miscellaneous hypoglycemics
Mineralocorticoids and mineralocorticoid antagonists
Sympatholytics: Alpha-2 agonists
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
Nonbenzodiazepine anticonvulsants
Atypical antipsychotics
Atypical antidepressants
Typical antipsychotics
Lithium
Monoamine oxidase inhibitors
Selective serotonin reuptake inhibitors
Serotonin and norepinephrine reuptake inhibitors
Tricyclic antidepressants
Anti-parkinson medications
Cholinomimetics: Direct agonists
Cholinomimetics: Indirect agonists (anticholinesterases)
Muscarinic antagonists
Headaches: Clinical
Migraine medications
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Antigout medications
Folate (Vitamin B9) deficiency
Vitamin D
Fat-soluble vitamin deficiency and toxicity: Pathology review
Mumps virus
Measles virus
Rubella virus
Bordetella pertussis (Whooping cough)
Poliovirus
Pediatric infectious rashes: Clinical

Transcript

Watch video only

With atopic dermatitis, dermatitis refers to skin inflammation, while “atopic” comes from the Greek word “atopia” meaning “out of place”. This phrase reflects the idea that in atopic dermatitis, the immune system overreacts to everyday, harmless substances, such as dust and pollen, as if they were dangerous, subsequently triggering inflammation and an extremely itchy rash. Atopic dermatitis, also known as atopic eczema, is a chronic, relapsing skin condition that’s particularly common among young children, but it can also persist well into adulthood.

Now, the skin is the body’s natural barrier that protects you from environmental substances and microbes. The outer layer of your skin called the epidermis, has four layers stacked up like a protective team. At the bottom is the stratum basale, followed by the stratum spinosum, then the stratum granulosum. The outermost layer and the front line of the skin barrier is the stratum corneum. Think of it as a brick wall. In this wall, bricks represent dead, flattened skin cells called corneocytes, which lock in moisture and keep allergens, irritants, and microbes out. But even the strongest wall needs reinforcement, and that’s where filaggrin comes in. This special protein works like rebar inside the wall. It links neighboring cells, flattens them out, and gives the skin its strength and flexibility.

At the heart of atopic dermatitis is a complex interaction between genetics, environmental factors, and the immune system.

On the genetic side, many individuals have mutations in the gene that encodes filaggrin. Without enough functional filaggrin, the wall loses its strength and cracks open leaving our body vulnerable. In other words, the skin loses its ability to retain moisture and keep out harmful substances.

Moreover, this compromised skin barrier opens the door to environmental triggers and allergens, such as dust mites and pollen. But here’s the thing. The immune system is always on alert, with antigen-presenting cells as frontline scouts constantly gathering intelligence on potential threats.

So, when something makes its way through the damaged skin, these immune scouts spring into action. They capture the intruder through a process called phagocytosis and break it down. Next, they present some of its fragments, known as antigens, on their surface. It’s their way of signalling to the immune system: “We have an intruder!” Using these antigens, they alert Th2 helper T cells to release pro-inflammatory cytokines called interleukins, which signal other immune cells to jump into action.

Interleukin 5 activates eosinophils to join the response, while interleukins 4 and 13 stimulate B cells to differentiate into plasma cells. Next, these plasma cells begin producing allergen-specific IgE antibodies, which latch onto mast cells and prepare them for future encounters.

When the body meets the same allergen again, the allergen cross-links the IgE on the surface of mast cells, triggering the release of histamine and other inflammatory mediators. This IgE-mediated immune response, known as type I hypersensitivity, results in the hallmark symptoms of atopic dermatitis, including erythema, swelling, and intense itching. Itching leads to scratching, and scratching makes things worse by further damaging the already fragile skin barrier.

Additionally, a sneaky bacterium called Staphylococcus aureus takes advantage of the cracked skin. The bacterium colonizes damaged areas and releases toxins that stimulate the immune system even more, adding fuel to the already raging fire of inflammation.

But the immune system doesn’t stop at the skin. If a person keeps encountering the same allergen, the reaction can escalate, and the immune response can spread beyond the skin. This occurs when Th2 cells slip into the bloodstream and travel to the lungs, where they can trigger asthma. Later, they can reach the nasal passages and cause allergic rhinitis. This step-by-step progression is called the atopic march.

Sources

  1. "Robbins Basic Pathology. ISBN 0323353177 " Elsevier (2017-03-28)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2) ISBN: 1259644030" McGraw-Hill Education (2018-08-13)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E. ISBN: 1260026507" McGraw-Hill Education (2018-11-26)
  4. "Atopic Dermatitis: Skin-Directed Management. 134(6), e1735-e1744. " Pediatrics (2014)
  5. "Management of difficult and severe eczema in childhood. 345(jul23 2), e4770-e4770. " BMJ (2012)